Katharine E. Spink
Direttore operativo presso Dark Horse Consulting Group, Inc.
Profilo
Katharine E.
Spink is currently the Chief Operating Officer & Managing Partner at Dark Horse Consulting Group, Inc. She previously worked as the Program Director at Cardiovascular Disease Foundation, Inc. from 2007 to 2008, as the VP-Regenerative Medicine Programs Operations at Geron Corp.
from 2003 to 2011, and as the Chief Operating Officer & Vice President at Asterias Biotherapeutics, Inc. from 2013 to 2018.
Spink received her undergraduate degree from Rice University and her doctorate from Stanford University School of Medicine.
Posizioni attive di Katharine E. Spink
| Società | Posizione | Inizio |
|---|---|---|
Dark Horse Consulting Group, Inc.
 Dark Horse Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Dark Horse Consulting Group, Inc. develops cell and gene therapy products. The firm offers process development, custom device development, project and program management, financing and diligence, manufacturing support and preclinical development services. The company was founded by Anthony H. Davies in 2014 and is headquartered in Campbell, CA. | Direttore operativo | 01/01/2018 |
Precedenti posizioni note di Katharine E. Spink
| Società | Posizione | Fine |
|---|---|---|
| ASTERIAS BIOTHERAPEUTICS INC | Direttore operativo | 19/01/2018 |
| Cardiovascular Disease Foundation, Inc. | Corporate Officer/Principal | 01/01/2008 |
| GERON CORPORATION | Direttore operativo | - |
Formazione di Katharine E. Spink
| Rice University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GERON CORPORATION | Health Technology |
| Aziende private | 3 |
|---|---|
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
| Cardiovascular Disease Foundation, Inc. | |
Dark Horse Consulting Group, Inc.
Dark Horse Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Dark Horse Consulting Group, Inc. develops cell and gene therapy products. The firm offers process development, custom device development, project and program management, financing and diligence, manufacturing support and preclinical development services. The company was founded by Anthony H. Davies in 2014 and is headquartered in Campbell, CA. | Commercial Services |
- Borsa valori
- Insiders
- Katharine E. Spink
